Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization

Blood

Volumn 103, Issue 5, 2004, Pages 1580-1585

  Papayannopoulou, Thalia ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTEGRIN;

BONE MARROW; CELL MIGRATION; CELLULAR DISTRIBUTION; HEMATOPOIETIC CELL; HUMAN; PRIORITY JOURNAL; REVIEW; STEADY STATE; STEM CELL MOBILIZATION;

EID: 1442357036     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1595     Document Type: Review

References (55)

1. Whetton AD, Graham GJ. Homing and mobilization in the stem cell niche. Trends Cell Biol. 1999;9:233-238.
2. Fu S, Liesveld J. Mobilization of hematopoietic stem cells. Blood Rev. 2000;14:205-218.
3. Kronenwett R, Martin S, Haas R. The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells. Stem Cells. 2000;18:320-330.
4. Link DC. Mechanisms of granulocyte colony-stimulating factor-induced hematopoietic progenitor-cell mobilization. Semin Hematol. 2000;37:25-32.
5. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973-981.
6. Pelus LM, Horowitz D, Cooper SC, King AG. Peripheral blood stem cell mobilization - a role for CXC chemokines. Crit Rev Oncol Hematol. 2002;43:257-275.
7. Thomas J, Liu F, Link DC, Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr Opin Hematol. 2002;9:183-189.
8. null mice. Leukemia. 2002;16:1992-2003.
9. Hattori K, Heissig B, Rafii S. The regulation of hematopoietic stem cell progenitor mobilization by chemokines SDF-1. Leuk Lymphoma. 2003;44:575-582.
10. Pruijt JFM, Verzaal P, Van Os R, et al. Neutrophils are indispensable for hematopoietic stem cell mobilization by interleukin-8 in mice. Proc Natl Acad Sci USA. 2002;99:6228-6233.
11. Jilma B, Hergovich N, Homoncik M, et al. Granulocyte colony-stimulating factor (G-CSF) down-regulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans. Br J Haematol. 2000;111:314-320.
12. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood, 2001;98:1289-1297.
13. Lévesque JP, Hendy J, Takamatsu Y, Williams B, Winkler IG, Simmons PJ. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol. 2002;30:430-439.
14. Lévesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CSCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003;110:187-196.
15. Hermant B, Bibert S, Concord E, et al. Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration. J Biol Chem. 2003;278:14002-14012.
16. El Ouriaghli R, Fujiwara H, Melenhorst J, Sconocchia G, Hensel N, Barrett AJ. Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis. Blood. 2003;101:1752-1758.
17. Proost P, Struyf S, Schols D, et al. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor 1alpha. FEBS Lett. 1998;432:73-76.
18. Liu F, Levésque J-P, Takamatsu Y, et al. Characterization of hematopoietic progenitor mobilization by G-CSF in protease deficient mice [abstract]. Blood 2002;100:611a.
19. Christopherson KW, Cooper S, Broxmeyer HE. CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice. Exp Hematol. 2003;31:1126-1134.
20. Pruijt JFM, Fibbe WE, Laterveer L, et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci U S A. 1999;96:10863-10868.
21. 4. Blood. 2004;103:110-119.
22. Moore MAS, Hattori K, Heissig B, et al. Mobilization of endothelial and hematopoietic stem can progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. In: Hematopoietic Stem Cells 2000. Basic and Clinical Sciences, Third International Conference. Orlic D, Brümmendorf TH, Sharkis SJ, Kanz L, eds. New York, NY: New York Academy of Sciences; 2002:36-47.
23. Shen H, Cheng T, Olszak I, et al. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J Immunol. 2001;166:5027-5033.
24. Liles WC, Broxmeyer HE, Rodger E, et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood. 2003;102:2728-2730.
25. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells block tumor angiogenesis and growth. Nat Med. 2001;7:1194-1201.
26. Kozuka T, Ishimaru F, Fujii K, et al. Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Bone Marrow Transplant. 2003;31:651-654.
27. King AG, Dillon S, Horowitz D, et al. Mechanism of action of truncatad GRO((SB-251353)-induced stem cell mobilization: role of the CXCR2 receptor and matrix metalloproteinase-9 (MMP-9) enzyme activity [abstract]. Exp Hematol. 1999;27:127a.
28. Wright DE, Bowman EP, Wagers AJ, Johnson FL, Weissman IL. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med. 2002;195:1145-1154.
29. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokines SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185:111-120.
30. Hattori KH, Heissig B, Tashiro K, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 2001;97:3354-3360.
31. Moore MAS. Cytokine and chemokines networks influencing stem cell proliferation, differentiation, and marrow homing. J Cell Biochem. 2002;38:29-38.
32. Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CSCR4. Nat Immunol. 2002;3:687-694.
33. Onai N, Zhang Y, Yoneyama H, Kitamura T, Ishikawa S, Matsushima K. Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrow-hematopoietic progenitor cells expressing SDF-1 intrakine. Blood. 2000;96:2074-2080.
34. Papayannopoulou T, Priestley GV, Bonig H, Nakamoto B. The role of G-protein signaling in hemopoietic stem/progenitor cell mobilization, Blood. 2003;101:4739-4747.
35. Jo D-Y, Hwang J-H, Kim J-M, Yun H-J, Kim S. Human bone marrow endothelial cells elaborate non-stromal-cell-derived factor-1 (SDF-1)-dependent chemoattraction and SDF-1-dependent transmigration of haematopoietic progenitors. Br J Haematol. 2003;121:649-652.
36. Whetton AD, Lu Y, Pierce A, Carney L, Spooncer E. Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1. Blood. 2003;102:2798-2802.
37. Yang FC, Atkinson SJ, Gu Y, et al. Rac and cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization. Proc Natl Acad Sci U S A. 2001;98:5614-5618.
38. Hernandez PA, Gorlin RJ, Lukens JN, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet. 2003;34:70-74.
39. Lacout C, Haddad E, Sabri S, et al. A defect in hematopoietic stem cell migration explains the non-random X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome. Blood. 2003;102:1282-1289.
40. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997;89:2233-2258.
41. Oostendorp RA, Dormer P. VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells. Leuk Lymphoma. 1997;24:423-435.
42. Matsunaga T, Takemoto N, Sato T, et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med. 2003;9:1158-1165.
43. Scott LM, Priestley GV, Papayannopoulou T. Deletion of α4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration and homing. Mol Cell Biol. 2003;23:9349-9360.
44. Gu Y, Filippi M-D, Cancelas JA, et al. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science. 2003;302:445-449.
45. Papayannopoulou T, Priestley GV, Nakamoto B. Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood. 1998;91:2231-2239.
46. Papayannopoulou T, Priestley GV, Nakamoto B, Zafiropoulos V, Scott LM, Harlan JM. Synergistic mobilization of hemopoietic progenitor cells using concurrent β1 and β2 integrin blockade or β2-deficient mice. Blood. 2001;97:1282-1288.
47. + cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies. J Hematother Stem Cell Res. 2003;12:425-434.
48. Hasegawa M, Baldwin TM, Metcalf D, Foote SJ. Progenitor cell mobilization by granulocyte colony-stimulating factor controlled by loci on chromosomes 2 and 11. Blood. 2000;95:1872-1874.
49. de Haan G, Bystrykh LV, Weesing E, et al. A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood. 2002;100:2056-2062.
50. Henckaerts E, Geiger H, Langer JC, Rebollo P, Van Zant G, Snoeck HW. Genetically determined variation in the number of phenotypically defined hematopoietic progenitor and stem cells and in their response to early-acting cytokines. Blood. 2002;99:3947-3954.
51. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Science. 2001;294:1933-1936.
52. Abkowitz JL, Robinson AE, Kale S, Long MW, Chen J. The mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood. 2003;102:1249-1253.
53. Scott LM, Priestley GV, Koni P, Papayannopoulou T. Adult mice with conditional VCAM-1 ablation show altered hemopoietic progenitor biodistribution, homing and regeneration patterns [abstract]. Blood. 2003;102:61a.
54. Broxmeyer HE, Cooper S, Hangoc G, Gao JL, Murphy PM. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1. J Exp Med. 1999;189:1987-1992.
55. Ratajczak J, Reca R, Kucia M, et al. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic sterm/progenitor cells in bone marrow: implications for the use of the C3aR antagonist as a new mobilization-facilitating agent [abstract]. Blood. 2003;102:114a.